Skip to content
Companies

Hyperion Surgical

Robot that places IV catheters under ultrasound guidance

Raised to date

$13.2M

of $23.7M offered across 1 Form D filing

Still open
$10.6M
Investors
42
Last filed
Jul 8, 2026

About

Hyperion Surgical is a medical technology company developing robotic and AI-enabled systems for vascular access and interventional procedures. Its lead product, the Ivy robotic vascular access platform, automates peripheral IV catheterization by combining continuous ultrasound imaging, AI vessel recognition, robotic probe stabilization, and robotic needle and catheter insertion. In 2025 the company completed a first-in-human study that it describes as the world's first robotic-assisted IV catheterization, and it plans an FDA submission and further clinical evaluation ahead of commercialization. The company was founded by neurosurgeon Dr. Eric Peterson and operates from South Florida.

Ivy replaces the two-handed, operator-dependent technique of ultrasound-guided IV placement with a semi-autonomous no-touch procedure, targeting the difficult-access patients where manual first-stick failure rates can exceed 50%.

Funding

  • EquityFiled Jul 8, 2026Form D
    $13.2M/ $23.7M

Product

Ivy robotic vascular access platform

Medical robotics

A robotic, AI-guided system that performs peripheral intravenous catheterization under continuous ultrasound visualization.

  • Continuous ultrasound visualization with AI vessel recognition
  • Robotic needle and catheter insertion
  • Automated ultrasound probe stabilization, removing manual handheld manipulation

Built for

US hospitals and health systems, specifically emergency departments, inpatient units, and outpatient centers performing peripheral IV catheterization

People on file